Q1 Stelara all 3:30 min > 15 mark

Name:

What is MOA of Stelara?

Positioning statement (Stelara in PSO) is FOR:

In Stelara PSO positioning statement: Stelara Provides a unique combination of

In stelara PSO positioning statement: so patinent stay on the treatment and feel _______ for the long term

Stelara is the only anti-IL-23/IL-12 biologic to provide proven efficacy and reliable safety through 9 years clinical trial program and 5 years of RWE

Stelara is also indicated for PSO patients aged 12-17 years old

Weaknesses of Enbrel are:

UC is less urgent to treat

In IBD unmet needs, patients seek: